FindTrial
Sign In

Efficacy of AHP Hemostatic Powder In Patients With Acute Gastrointestinal Bleeding: A Randomized Controlled Trial

Efficacy of AHP Hemostatic Powder In Patients With Acute Gastrointestinal Bleeding: A Randomized Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400090761
Enrollment
Unknown
Registered
2024-10-12
Start date
2024-10-15
Completion date
Unknown
Last updated
2024-10-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastrointestinal bleeding

Interventions

The treatment group:AHP haemostatic powder for haemostatic treatment
The control group:Traditional haemostatic treatment

Sponsors

The 963rd Hospital of the Joint Logistics Support Force of the Chinese People’s Liberation Army
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: (1) Patients with gastrointestinal bleeding; (2) No gender limitation; (3) Understand and sign informed consent; (4) Age ranged from 18 to 90 years

Exclusion criteria

Exclusion criteria: (1) Allergic to polyoxyethylene; (2) Pregnancy and lactation; (3) Severe cardiopulmonary diseases; (4) Patients with mental illness;

Design outcomes

Primary

MeasureTime frame
Immediate hemostasis rate;—

Secondary

MeasureTime frame
3 day rebleeding rate;7 day rebleeding rate;—

Countries

China

Contacts

Public ContactSu Dongshuai

The 963rd Hospital of the Joint Logistics Support Force of the Chinese People’s Liberation Army

694161202@qq.com+86 186 9922 6287

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026